Allogene Therapeutics, Inc. · NASDAQ:ALLO

Citadel Advisors LLC reported a 6.10% stake in Allogene Therapeutics, Inc. (Schedule 13G)

Event Jul 9, 2025 · Filed Jul 16, 2025

Citadel Advisors LLC reported a 6.10% stake in Allogene Therapeutics, Inc., 13,346,151 shares, as a passive investor on Jul 9, 2025. Filed Jul 16, 2025 (Schedule 13G).

Stake
6.10%
Shares
13,346,151
Intent
Passive
What changed
Crossed above 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC4.70%10,203,329
Citadel Advisors Holdings LP4.70%10,203,329
Citadel GP LLC4.70%10,203,329
Citadel Securities LLC1.40%3,142,822
Citadel Securities Group LP1.40%3,142,822
Citadel Securities GP LLC1.40%3,142,822
Kenneth Griffin6.10%13,346,151

Source

View original at SEC

Related